One Theranos board member is standing by the Palo Alto, Calif.-based blood testing startup despite the onslaught of doubts reported by the media.
Former Wells Fargo CEO Dick Kovacevich said Thursday on CNBC's "Squawk Box" he still believes in the company's technology and that there is a lot of misinformation out there. He also said more accurate information is on the way, according to CNBC.
"I think these are all normal things that happen with a startup, and there's been excessive publicity for something that is not unusual in start-ups," he said.
Editor's Note: This article was updated on June 3, 2016 at 10:25 a.m. CT. It previously stated Dick Kovacevich was the CEO of Wells Fargo. He is a former CEO of Wells Fargo. We regret this error.
More articles on leadership and management:
Is CEO pay increasing or decreasing? It depends
Can 'front-stabbing' cultivate a culture of happiness at work?
Rome Memorial Hospital names former CEO to board: 3 things to know